How to Perform a Hazardous Drug Risk Assessment in the Compounding Pharmacy
There is a looming deadline on December 1, 2019 and that is the implementation of USP chapter <800>-Hazardous Drugs, Handling in Healthcare Settings.
A comprehensive risk assessment of every single hazardous drug (HD) on the NIOSH hazardous drug list is not absolutely required, yet you will need to review the list and identify those drugs and dosage forms that you handle in your pharmacy. In the absence of the assessment of risk, you must implement all containment strategies defined in the chapter. Full implementation of the engineering controls necessary to maintain negative pressure can be an expensive endeavor with residual energy costs, so taking the time to perform a risk assessment may prove to be financially advantageous. What we will outline and explain in this paper is the process of risk assessment is relatively simple and the process will surely uncover truths about our current workflow habits.
Fill out the form below to read the white paper.
Working towards USP 800 compliance?